SRTS
Price
$7.09
Change
-$0.12 (-1.66%)
Updated
Dec 20, 04:59 PM (EDT)
46 days until earnings call
VAPO
Price
$2.17
Change
-$0.01 (-0.46%)
Updated
Sep 19 closing price
Ad is loading...

SRTS vs VAPO

Header iconSRTS vs VAPO Comparison
Open Charts SRTS vs VAPOBanner chart's image
Sensus Healthcare
Price$7.09
Change-$0.12 (-1.66%)
Volume$3.84K
CapitalizationN/A
Vapotherm
Price$2.17
Change-$0.01 (-0.46%)
Volume$51.53K
CapitalizationN/A
SRTS vs VAPO Comparison Chart
Loading...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VAPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SRTS vs. VAPO commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRTS is a Hold and VAPO is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (SRTS: $7.10 vs. VAPO: $2.17)
Brand notoriety: SRTS and VAPO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SRTS: 109% vs. VAPO: 100%
Market capitalization -- SRTS: $61.97M vs. VAPO: $18.42M
SRTS [@Medical Specialties] is valued at $61.97M. VAPO’s [@Medical Specialties] market capitalization is $18.42M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRTS’s FA Score shows that 0 FA rating(s) are green whileVAPO’s FA Score has 0 green FA rating(s).

  • SRTS’s FA Score: 0 green, 5 red.
  • VAPO’s FA Score: 0 green, 5 red.
According to our system of comparison, SRTS is a better buy in the long-term than VAPO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRTS’s TA Score shows that 5 TA indicator(s) are bullish while VAPO’s TA Score has 2 bullish TA indicator(s).

  • SRTS’s TA Score: 5 bullish, 4 bearish.
  • VAPO’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, VAPO is a better buy in the short-term than SRTS.

Price Growth

SRTS (@Medical Specialties) experienced а -12.99% price change this week, while VAPO (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

SRTS is expected to report earnings on Feb 06, 2025.

VAPO is expected to report earnings on Nov 08, 2023.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRTS($62M) has a higher market cap than VAPO($18.4M). SRTS YTD gains are higher at: 200.847 vs. VAPO (117.000). SRTS has higher annual earnings (EBITDA): 79K vs. VAPO (-47.02M). SRTS has more cash in the bank: 23.1M vs. VAPO (14.4M). SRTS has less debt than VAPO: SRTS (783K) vs VAPO (107M). VAPO has higher revenues than SRTS: VAPO (67.6M) vs SRTS (24.4M).
SRTSVAPOSRTS / VAPO
Capitalization62M18.4M337%
EBITDA79K-47.02M-0%
Gain YTD200.847117.000172%
P/E Ratio126.00N/A-
Revenue24.4M67.6M36%
Total Cash23.1M14.4M160%
Total Debt783K107M1%
FUNDAMENTALS RATINGS
SRTS vs VAPO: Fundamental Ratings
SRTS
VAPO
OUTLOOK RATING
1..100
5750
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
34
Fair valued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
49100
PRICE GROWTH RATING
1..100
3840
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VAPO's Valuation (34) in the Medical Specialties industry is in the same range as SRTS (60). This means that VAPO’s stock grew similarly to SRTS’s over the last 12 months.

SRTS's Profit vs Risk Rating (71) in the Medical Specialties industry is in the same range as VAPO (100). This means that SRTS’s stock grew similarly to VAPO’s over the last 12 months.

SRTS's SMR Rating (49) in the Medical Specialties industry is somewhat better than the same rating for VAPO (100). This means that SRTS’s stock grew somewhat faster than VAPO’s over the last 12 months.

SRTS's Price Growth Rating (38) in the Medical Specialties industry is in the same range as VAPO (40). This means that SRTS’s stock grew similarly to VAPO’s over the last 12 months.

SRTS's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as VAPO (100). This means that SRTS’s stock grew similarly to VAPO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRTSVAPO
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 18 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VAPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X97224.730000-531.203100
-0.54%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

SRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTS has been loosely correlated with LUNG. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTS jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
-1.53%
LUNG - SRTS
57%
Loosely correlated
+3.71%
VAPO - SRTS
35%
Loosely correlated
N/A
QDEL - SRTS
27%
Poorly correlated
+4.21%
NVST - SRTS
25%
Poorly correlated
+3.72%
NNOX - SRTS
24%
Poorly correlated
+2.89%
More